The value of patient-reported outcomes in early-phase clinical trials

被引:27
|
作者
Retzer, Ameeta [1 ,2 ]
Aiyegbusi, Olalekan Lee [1 ,2 ,3 ,4 ]
Rowe, Anna [3 ,5 ]
Newsome, Philip N. [3 ,6 ]
Douglas-Pugh, Jessica [5 ]
Khan, Sheeba [3 ,6 ,7 ]
Mittal, Saloni [8 ]
Wilson, Roger [9 ]
O'Connor, Daniel [10 ]
Campbell, Lisa [10 ]
Mitchell, Sandra A. [11 ]
Calvert, Melanie [1 ,2 ,3 ,4 ,12 ,13 ]
机构
[1] Univ Birmingham, Inst Appl Hlth Res, Ctr Patient Reported Outcomes Res, Birmingham, W Midlands, England
[2] Univ Birmingham, Appl Res Ctr West Midlands, Natl Inst Hlth Res, Birmingham, W Midlands, England
[3] Univ Hosp Birmingham NHS Fdn Trust, Birmingham Biomed Res Ctr, Natl Inst Hlth Res, Birmingham, W Midlands, England
[4] Birmingham Hlth Partners Ctr Regulatory Sci & Inn, Birmingham, W Midlands, England
[5] Univ Birmingham, Canc Res UK Clin Trials Unit, Birmingham, W Midlands, England
[6] Univ Birmingham, Inst Immunol & Immunotherapy, Ctr Liver & Gastrointestinal Res, Birmingham, W Midlands, England
[7] Univ Hosp Birmingham NHS Fdn Trust, Liver Unit, Birmingham, W Midlands, England
[8] Univ Birmingham, Birmingham, W Midlands, England
[9] NCRI Consumer Forum Natl Canc Res Inst, London, England
[10] Med & Healthcare Prod Regulatory Agcy MHRA, London, England
[11] NIH, Outcomes Res Branch, Div Canc Control & Populat Sci, Rockville, MD USA
[12] Univ Birmingham, Surg Reconstruct & Microbiol Res Ctr, Natl Inst Hlth Res, Birmingham, W Midlands, England
[13] Univ Birmingham, UK SPINE, Birmingham, W Midlands, England
基金
“创新英国”项目; 英国科研创新办公室;
关键词
VALIDITY;
D O I
10.1038/s41591-021-01648-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
If used correctly, patient-reported outcomes can provide preliminary evidence of efficacy and tolerability from a patient perspective, as well as supporting regulatory review.
引用
下载
收藏
页码:18 / 20
页数:3
相关论文
共 50 条
  • [41] PATIENT-REPORTED OUTCOMES IN COMMERCIAL PEDIATRIC ONCOLOGY CLINICAL TRIALS
    Murugappan, M.
    King-Kallimanis, B. L.
    Reaman, G. H.
    Bhatnagar, V
    Horodniceanu, E. G.
    Bouchkouj, N.
    Kluetz, P. G.
    VALUE IN HEALTH, 2021, 24 : S59 - S59
  • [42] PATIENT-REPORTED OUTCOMES (PROS) IN OVARIAN CANCER CLINICAL TRIALS
    Pease, S.
    Barsdorf, A., I
    VALUE IN HEALTH, 2015, 18 (03) : A210 - A210
  • [43] Integration of patient-reported outcomes in multiregional confirmatory clinical trials
    Gnanasakthy, Ari
    DeMuro, Carla
    Boulton, Caroline
    CONTEMPORARY CLINICAL TRIALS, 2013, 35 (01) : 62 - 69
  • [44] The prognostic significance of patient-reported outcomes in cancer clinical trials
    Gotay, Carolyn C.
    Kawamoto, Crissy T.
    Bottomley, Andrew
    Efficace, Fabio
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (08) : 1355 - 1363
  • [45] Patient-reported Outcomes (PROs) in clinical trials in paediatric dentistry
    Gilchrist, Fiona
    Marshman, Zoe
    INTERNATIONAL JOURNAL OF PAEDIATRIC DENTISTRY, 2020, 31 : 31 - 37
  • [46] Standardizing patient-reported outcomes assessment in cancer clinical trials: A patient-reported outcomes measurement information system initiative
    Garcia, Sofia F.
    Cella, David
    Clauser, Steven B.
    Flynn, Kathryn E.
    Lad, Thomas
    Lai, Jin-Shei
    Reeve, Bryce B.
    Smith, Ashley Wilder
    Stone, Arthur A.
    Weinfurt, Kevin
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (32) : 5106 - 5112
  • [47] Patient-Reported Outcomes in Cardiovascular Trials
    Creber, Ruth Masterson
    Spadaccio, Cristiano
    Dimagli, Arnaldo
    Myers, Annie
    Taylor, Brittany
    Fremes, Stephen
    CANADIAN JOURNAL OF CARDIOLOGY, 2021, 37 (09) : 1340 - 1352
  • [48] Trends in patient -reported outcome (PRO) use in early-phase oncology trials
    Lai-Kwon, Julia
    Yin, Zhulin
    Minchom, Anna
    Yap, Christina
    QUALITY OF LIFE RESEARCH, 2020, 29 (SUPPL 1) : S53 - S53
  • [49] The Value of Patient-Reported Outcomes in Single-Arm Cancer Trials
    Di Maio, Massimo
    CANCER INVESTIGATION, 2023, 41 (05) : 491 - 494
  • [50] Assessing the Value of Patient-Reported Outcomes
    Mitchell, Matthew
    AMERICAN HEALTH AND DRUG BENEFITS, 2013, 6 (04): : 274 - 274